PREEMPT trial: Progesterone offers ‘no benefit’ to women with first-trimester bleeding

SAN DIEGO — Progesterone was not effective at preventing miscarriage or prematurity in patients who presented with first-trimester vaginal bleeding, according to results of the PREEMPT trial.
Findings from the multicenter, double-blind, randomized study call into question previous evidence that suggested the hormone could improve clinical outcomes.
“First-trimester bleeding is a common problem in early pregnancy that is associated with an increased risk of prematurity,” Haim A. Abenhaim, MD, MPH, FRCSC, an OB/GYN and maternal-fetal medicine specialist at McGill University’s

SAN DIEGO — Progesterone was not effective at preventing miscarriage or prematurity in patients who presented with first-trimester vaginal bleeding, according to results of the PREEMPT trial.
Findings from the multicenter, double-blind, randomized study call into question previous evidence that suggested the hormone could improve clinical outcomes.
“First-trimester bleeding is a common problem in early pregnancy that is associated with an increased risk of prematurity,” Haim A. Abenhaim, MD, MPH, FRCSC, an OB/GYN and maternal-fetal medicine specialist at McGill University’s